Home › Blood Disorders › NCT06222164

The Use of Residual De-identified Specimens and/or Samples From Patients for Clinical Research

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

1. Specimen/sample, peripheral blood (PB), bone marrow (BM), genomic DNA (gDNA) and/or formalin-fixed paraffin-embedded tissue (FFPE) from patients whose specimens/samples have been sent to LabPMM for clinical testing
2. Donor Age ≥ 18 years

Exclusion Criteria:

1. Sample/specimen has been obtained from a third-party vendor with a Materials Transfer Agreement (MTA) on file with LabPMM
2. The specimens/samples have previously been enrolled in a clinical study

About the study

Acquire residual human specimens and/or samples from patient samples which were sent for testing at LabPMM, LLC for Clinical Research

Sponsor: Invivoscribe, Inc. · Participants: 2,000 · Started: Mar 30, 2024

Contact the study team

• Andrew Schut · Phone: +1 858.224.6600

Official record on ClinicalTrials.gov — NCT06222164

Locations in the U.S.

Conditions

• Blood Disorders

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.